Brian Harvey

Transcend Therapeutics, Inc. develops and markets pharmaceutical products. It offers its products for oxidative stress, cytokine dysfunction, and multiple organ dysfunctions. The company was founded by Dennis I. Goldberg and Gary W. Pace in 1992 and is headquartered in Cambridge, MA.

MPM Acquisition Corp. was incorporated in the State of Delaware on February 4, 2008. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The company was formed as a vehicle to pursue a business combination. As such, the business purpose of the company is to seek the acquisition or merger with, an existing company. The company is headquartered in Boston, MA.

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.

Passport Systems, Inc. provides scanning system services. It develops active and passive solutions to automatically detect, localize, and identify concealed threats and contraband for a broad range of applications, including pedestrian, vehicle, and fixed-facility-based approaches. The firm offers an automated, non-intrusive Cargo Scanning System that has the capability to analyze the composition of materials and accurately identify the contents of a container, including commercial items, contraband, fissile materials, explosives, and other materials. The company was founded by William Bertozzi, Robert J. Ledoux and Stewart K. Hall in December 2002 and is headquartered in Billerica, MA.

Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA.

Natick-based Transfusion Technologies Corp., is a private company that specializes in blood separation systems. It manufactures medical devices.

Shiprock Capital LLC (Shiprock Capital) is a venture capital firm founded in 1999 by Richard C. Shipley. The firm is headquartered in Wellesley, MA.